Excel Venture Management
Status
ACTIVE
Global HQ
United States
Countries of investment
- USA
Investment stages
- Seed
Industries
- Health Tech
- Agtech
- Sustainable Energy
- Defense Tech
About
Excel Venture Management is a leading investment firm dedicated to fostering and advancing innovative enterprises that harness transformative life science technologies. Our focus is on addressing critical challenges within the healthcare sector and adjacent fields, ensuring our portfolio includes a diverse array of companies specializing in healthcare IT, diagnostics, medical devices, and therapeutics. Through strategic investments and deep industry expertise, Excel Venture Management aims to drive significant advancements that improve patient outcomes and enhance the overall efficiency of healthcare delivery. We are committed to collaborating with visionary entrepreneurs to create lasting impact and value in the life sciences landscape.
Excel Venture Management is a leading investment firm dedicated to fostering and advancing innovative enterprises that harness transformative life science technologies. Our focus is on addressing critical challenges within the healthcare sector and adjacent fields, ensuring our portfolio includes a diverse array of companies specializing in healthcare IT, diagnostics, medical devices, and therapeutics. Through strategic investments and deep industry expertise, Excel Venture Management aims to drive significant advancements that improve patient outcomes and enhance the overall efficiency of healthcare delivery. We are committed to collaborating with visionary entrepreneurs to create lasting impact and value in the life sciences landscape.
Investment Thesis
Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Manager's Experience
Backed by over two decades of experience in venture capital, the fund manager has successfully navigated investments primarily in technology and healthcare sectors across North America and Europe. With a portfolio that includes more than 50 deals, they have achieved several notable exits, showcasing an operator-first investment approach that emphasizes hands-on support for portfolio companies. Their strategic focus on early to growth-stage investments highlights a commitment to identifying transformative opportunities in emerging markets. A data-driven methodology underpins their investment decisions, ensuring a robust analytical framework for assessing potential success.
Team
Rick Blume
Juan Enriquez
Juan Enriquez
Jeanne Henry
Gaye Bok
Enrico Petrillo
Caleb Winder
Caleb Winder
Portfolio
Activate Networks
Aileron Therapeutics
Aventura
Ayogo
Biocius Life Sciences
Biotrove
Catch
ClearDATA
Cleveland HeartLab
Gemphire Therapeutics
IlluminOss
InfoBionic
Lantos Technologies
MedVentive
Molecular Templates
NanoMR
Neosensory
N-of-One
Oculus Health
Openwater
Orionis Biosciences
Qstream
Saladax
ShapeUp
Synthetic Genomics
Tetraphase Pharmaceuticals
Virgin Pulse
WellDoc
Zipongo.